Lifestyle
6 Simple Ways To Make Each of Your Kids Feel Special Every Day
These are small but powerful ways to ensure all of your children feel like a VIP.
Welcoming Ground-Level Condo in Menlo Park Listed on PropGOLuxury
Charming end-unit home offers bright, private living near Silicon Valley hubs
Judge Denies Bid to Pause TIDE Academy Closure Process
Federal judge finds no urgency to halt closure of Menlo Park STEM school
Sports
Hyo Joo Kim wins wire-to-wire at Fortinet Founders Cup
Korda's late charge falls short as Kim holds on for one-shot victory
Hyo Joo Kim Wins Fortinet Founders Cup
South Korean golfer holds off Nelly Korda for eighth LPGA Tour victory
Rose Zhang Completes Stanford Degree with Beer Brewing Paper
The two-time LPGA winner wraps up her communications degree with a final 10-page project on beer brewing.
Business
GRAIL Upgraded to Buy at TD Cowen
Analysts see upside potential in the cancer detection company's stock.
Joveo Named One of America's Best Startup Employers 2026 by Forbes
The honor places Joveo among the top 500 startups in the US, recognizing its exceptional growth, employee satisfaction, and innovation.
GRAIL Announces CEO Retirement and Successor Appointment
Bob Ragusa to retire as CEO, Josh Ofman, MD, MSHS, named as new CEO
Health
Women Need More Sleep Than Men But Get Less, Study Finds
Biological and social factors contribute to the 'gender sleep gap', experts say
Cannabis Compounds May Treat Common Liver Disease
Study finds CBD and CBG could reduce liver fat and improve metabolic health
AN2 Therapeutics to Advance Oral Epetraborole into Phase 2 for Polycythemia Vera
The biotech company plans to study the drug candidate for the rare blood disorder.
Finance
Robinhood Investor Sells Shares as Stock Price Fluctuates
Exchange Traded Concepts LLC reduces stake in the online brokerage firm amid market volatility.
Meta Platforms Shares Sold by Moody National Bank Trust Division
Institutional investor reduces stake in social media giant
Oruka Therapeutics and Clearmind Medicine Vie for Investor Dollars
Analysts see greater potential upside in Oruka Therapeutics despite Clearmind's lower valuation
